SMTL ID : 6qae.1

Human Butyrylcholinesterase in complex with (S)-N2-butyl-N1-(2-cycloheptylethyl)-3-(1H-indol-3-yl)-N1,N2-dimethylpropane-1,2-diamine

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.49 Å

Oligo State

monomer

Ligands

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.1: 2 residues within 4Å: Chain A: R.42, N.85 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.42, A:N.85

2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.2: 6 residues within 4Å: Chain A: P.363, G.364, S.366, N.369, N.370, I.372 No protein-ligand interaction detected (PLIP) NAG-NAG-FUC.3: 4 residues within 4Å: Chain A: N.269, N.273, L.277, F.306 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.277 Hydrogen bonds: A:F.306, A:V.308

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 2 residues within 4Å: Chain A: N.134, N.216 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.216 NAG.5: 2 residues within 4Å: Chain A: N.284, E.287 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.287 Water bridges: A:N.284 NAG.6: 4 residues within 4Å: Chain A: R.493, K.497, E.510, N.513 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:K.497, A:E.510 Hydrogen bonds: A:R.493, A:N.513 Water bridges: A:R.493

1 x HUK: butyl-[(2~{S})-1-[2-cycloheptylethyl(methyl)azaniumyl]-3-(1~{H}-indol-3-yl)propan-2-yl]-methyl-azanium(Non-covalent)

HUK.7: 20 residues within 4Å: Chain A: N.96, I.97, D.98, W.110, G.144, G.145, T.148, S.226, W.259, P.313, L.314, S.315, V.316, A.356, F.357, Y.360, F.426, W.458, H.466, Y.468 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:N.96, A:T.148, A:F.357, A:F.357, A:Y.360, A:F.426, A:W.458, A:Y.468 Hydrogen bonds: A:L.314 pi-Stacking: A:W.259, A:W.259

5 x SO4: SULFATE ION(Non-functional Binders)

SO4.8: 4 residues within 4Å: Chain A: Q.344, G.441, N.442, N.443 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Q.344, A:G.441, A:N.442, A:N.443 SO4.9: 5 residues within 4Å: Chain A: W.259, R.270, L.314, S.315, V.316 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:L.314, A:V.316 Water bridges: A:R.270, A:R.270 Salt bridges: A:R.270 SO4.10: 4 residues within 4Å: Chain A: R.498, S.515, T.516, T.536 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.498, A:T.516, A:T.516, A:T.536, A:T.536, A:T.536 SO4.11: 2 residues within 4Å: Chain A: R.375, Q.379 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.379 Salt bridges: A:R.375 SO4.12: 3 residues within 4Å: Chain A: K.351, Y.448, R.543 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.448 Salt bridges: A:K.351, A:R.543

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Meden, A. et al., Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease. Chem.Commun.(Camb.) (2019)

Release Date

2019-03-27

Peptides

Cholinesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cholinesterase

Related Entries With Identical Sequence